We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-1.13%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$103B
AUM Growth
+$1.83B
Cap. Flow
+$3.67B
Cap. Flow %
3.57%
Top 10 Hldgs %
46.02%
Holding
3,718
New
534
Increased
1,981
Reduced
979
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 7.11%
2 Financials 3.31%
3 Consumer Discretionary 2.07%
4 Healthcare 1.66%
5 Communication Services 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HVT icon
3526
Haverty Furniture Companies
HVT
$418M
$935 ﹤0.01%
+42
New +$995
KMPR icon
3527
Kemper
KMPR
$1.81B
$930 ﹤0.01%
+14
New +$923
LE icon
3528
Lands' End
LE
$378M
$920 ﹤0.01%
+70
New +$1.1K
ZUMZ icon
3529
Zumiez
ZUMZ
$330M
$920 ﹤0.01%
+48
New +$1.02K
CVGW
3530
DELISTED
Calavo Growers
CVGW
$918 ﹤0.01%
+36
New +$980
GDEN
3531
DELISTED
Golden Entertainment
GDEN
$916 ﹤0.01%
+29
New +$921
WKC icon
3532
World Kinect Corp
WKC
$2.06B
$908 ﹤0.01%
+33
New +$946
PSNL icon
3533
Personalis
PSNL
$1.25B
$907 ﹤0.01%
+157
New +$725
ETD icon
3534
Ethan Allen Interiors
ETD
$600M
$900 ﹤0.01%
+32
New +$949
LOCO icon
3535
El Pollo Loco
LOCO
$503M
$900 ﹤0.01%
+78
New +$983
IIIV icon
3536
i3 Verticals
IIIV
$419M
$899 ﹤0.01%
+39
New +$915
PLOW icon
3537
Douglas Dynamics
PLOW
$992M
$898 ﹤0.01%
+38
New +$962
ENFN
3538
DELISTED
Enfusion, Inc.
ENFN
$896 ﹤0.01%
+87
New +$841
SHOE
3539
Shoe Station Group
SHOE
$424M
$893 ﹤0.01%
27
-7,729
-100% -$280K
RIGL icon
3540
Rigel Pharmaceuticals
RIGL
$723M
$891 ﹤0.01%
+53
New +$1.02K
MLNK
3541
DELISTED
MeridianLink
MLNK
$888 ﹤0.01%
+43
New +$947
RARE icon
3542
Ultragenyx Pharmaceutical
RARE
$2.46B
$883 ﹤0.01%
+21
New +$1.04K
LIVN icon
3543
LivaNova
LIVN
$4.47B
$880 ﹤0.01%
+19
New +$974
TYRA icon
3544
Tyra Biosciences
TYRA
$1.85B
$876 ﹤0.01%
+63
New +$1.14K
BHRB icon
3545
Burke & Herbert Financial Services Corp
BHRB
$1.48B
$873 ﹤0.01%
+14
New +$916
ATXS
3546
DELISTED
Astria Therapeutics
ATXS
$867 ﹤0.01%
+97
New +$1.03K
GTX icon
3547
Garrett Motion
GTX
$5.37B
$849 ﹤0.01%
+94
New +$780
ZYME icon
3548
Zymeworks
ZYME
$1.62B
$834 ﹤0.01%
+57
New +$797
SPB icon
3549
Spectrum Brands
SPB
$2.03B
$760 ﹤0.01%
+9
New +$815
GOOGL icon
3550
PUT
Alphabet (Google) Class A
GOOGL
$4.12T
$735 ﹤0.01%
+36,200
New +$6.33M

Similar funds

Creative Planning's Q4 2024 Portfolio in Review

As of Q4 2024, Creative Planning held 3,718 positions worth $103B, up 1.8% from $101B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Creative Planning deployed $3.67B of net new capital in Q4 2024, opening 534 new positions and adding to 1,981 existing holdings. Its largest new stake was VanEck IG Floating Rate ETF: 1,040,413 shares worth $26.5M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was WisdomTree Emerging Markets SmallCap Dividend Fund, an estimated $213M trimmed.

  • Creative Planning's largest Q4 2024 buy was VanEck IG Floating Rate ETF: 1,040,413 shares worth $26.5M.
  • Creative Planning added most to Vanguard Total Bond Market in Q4 2024, an estimated $649M increase.
  • Creative Planning's biggest Q4 2024 reduction was WisdomTree Emerging Markets SmallCap Dividend Fund, cutting an estimated $213M.
  • Creative Planning fully exited iShares iBonds Dec 2024 Term Treasury ETF in Q4 2024, selling an estimated $4.5M.
  • Creative Planning's ten largest holdings make up 46% of its $103B portfolio in Q4 2024.
  • Creative Planning opened 534 new positions and closed 136 in Q4 2024.
  • Creative Planning's portfolio value rose 1.8% quarter-over-quarter to $103B.

Based on Creative Planning's 13F filing for Q4 2024, filed 14 Feb 2025.